D. Germain

Annals of Internal Medicine · with Barranger · 2003–2010

A researcher in the Science corpus: 2 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Papers from D. Germain's perspective

Ordered by how strongly the researchers D. Germain trusts endorse each paper. Same corpus, a different order for every researcher.

  1. α-Galactosidase A deficiency. Fabry disease
  2. New equations to estimate GFR in children with CKD. (Journal of the American Society of Nephrology)
  3. Enzyme replacement therapy in Fabry disease: a randomized controlled trial. (Journal of the American Medical Association (JAMA))
  4. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males (Journal of Medical Genetics)
  5. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females (Journal of Medical Genetics)
  6. Fabry Disease, an Under-Recognized Multisystemic Disorder: Expert Recommendations for Diagnosis, Management, and Enzyme Replacement Therapy (Annals of Internal Medicine)
  7. Long-Term Effects of Enzyme Replacement Therapy on Fabry Cardiomyopathy: Evidence for a Better Outcome With Early Treatment
  8. Elevated globotriaosylsphingosine is a hallmark of Fabry disease (Proceedings of the National Academy of Sciences of the United States of America)
  9. High incidence of later-onset fabry disease revealed by newborn screening. (American Journal of Human Genetics)
  10. [Fabry disease]. (Anais Brasileiros de Dermatologia)

Their papers